Rxo (RXO) Other Accumulated Expenses (2021 - 2026)

Rxo (RXO) has reported Other Accumulated Expenses for 6 consecutive years, with $10.0 million the latest figure, recorded in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $10.0 million, down 9.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 million (down 9.09% YoY), and the FY2025 annual result was $10.0 million, down 61.54% from the prior year.
• Other Accumulated Expenses was $10.0 million for Q1 2026 at Rxo, roughly flat from $10.0 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $26.0 million in Q4 2024 and troughed at $5.0 million in Q3 2022.
• Average Other Accumulated Expenses over 5 years is $12.1 million, with a median of $12.0 million recorded in 2024.
• Year-over-year, Other Accumulated Expenses surged 283.33% in 2024 and tumbled 61.54% in 2025.
• Over 5 years, Other Accumulated Expenses stood at $14.0 million in 2022, then dropped by 7.14% to $13.0 million in 2023, then surged by 100.0% to $26.0 million in 2024, then sank by 61.54% to $10.0 million in 2025, then changed by 0.0% to $10.0 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $10.0 million in Q1 2026, $10.0 million in Q4 2025, and $12.0 million in Q3 2025.